Experience
Housey Pharmaceuticals, Inc.
Otsuka Pharmaceutical Co. Ltd.
Represented Otsuka Pharmaceuticals in a patent infringement suit concerning cell-based assay methods and kits. Housey requested that judgment be entered against it after the district court issued a Markman ruling favorable to the defendants. The Federal Circuit later affirmed the judgment.
Housey Pharmaceuticals, Inc. v. Otsuka Pharmaceutical Co. Ltd., 1:01-cv-00401, D. Del., Judge Robinson
Otsuka Pharmaceutical Co., Ltd. v. Teva Pharmaceuticals USA, Inc.
Otsuka Pharmaceutical Co.
Hartig Drug Co. Inc. v. Senju Pharmaceutical Co. Ltd.
Senju Pharmaceuticals Co. Ltd.
District court ruling maintains patent and regulatory protection of Otsuka’s Abilify®
Otsuka Pharmaceutical Co., Ltd.
Senju Pharmaceutical Co., Ltd. v. Apotex Inc.
Senju Pharmaceutical Co., Ltd.; Bausch + Lomb Inc.
NeXstar Pharmaceuticals v. Liposome Co.
NeXstar Pharmaceuticals
InnoPharma Licensing, Inc.; Lupin Ltd.; and Metrics, Inc. v. Senju Pharmaceuticals Co.
Bausch Health Companies
Mylan Pharmaceuticals Inc. v. Senju Pharmaceutical Co., Ltd.
Senju Pharmaceutical Co., Ltd.; Bausch & Lomb Incorporated
Otsuka Pharmaceutical Co., Ltd. v. Apotex Corp.
Otsuka Pharmaceutical Co., Ltd.
Apotex Inc. v. Senju Pharmaceutical
Senju Pharmaceuticals Co. Ltd.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.